SpicyIP

JANUARY 20, 2023

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement.

Patent Infringement 119

Patent Infringement Patent Patent Application Intellectual Property 119

Patently-O

MARCH 27, 2024

highlights tensions in the court’s interpretation of the patent infringement safe harbor under 35 U.S.C. § 271(e)(1) provides an exemption from patent infringement liability for certain activities related to seeking regulatory approval of drugs and medical devices. 193 (2005). 193 (2005). 271(e)(1).

Patent Infringement 44

Patent Infringement Patent Law Invention 44

Patently-O

AUGUST 3, 2023

by Dennis Crouch Moderna filed a patent infringement lawsuit against Pfizer and BioNTech in August 2022, alleging that the defendants COVID-19 vaccine infringes three patents related to Moderna’s mRNA vaccine technology. United States Patent Nos. 2005) (en banc). 10,898,574, 10,702,600, and 10,933,127.

Patent 97

Patent Patent Infringement Copying Technology 97

SpicyIP

MARCH 21, 2024

This is because they allow competitors to the patent applicant, who are more likely to be more familiar with the invention sought to being patented, to contribute to the examination process by bringing forth the latest “prior art” to the attention of the Patent Office.

Patent 52

Patent Patent Application Government Reporting 52

Patently-O

NOVEMBER 29, 2023

Specifically, the Board found MacNeil was entitled to a presumption that its evidence of commercial success, long-felt need, and industry praise related to its WeatherTech® product reflective of the inventiveness of the claims of the ’186 Patent. 408, 417 (2005). 101 as claiming only abstract ideas and no inventive concept.

Patent Law 73

Patent Law Law Patent Art 73

Patently-O

FEBRUARY 29, 2024

Background In 2005, AlexSam licensed its prepaid card patents to MasterCard in exchange for ongoing royalties based on the number of “Licensed Transactions.” The hook for the Federal Circuit was a declaratory judgment counterclaim filed by MasterCard seeking a ruling that an AlexSam patent was invalid.

Licensing 52

Licensing Contracts Patent Law Patent 52

LexBlog IP

OCTOBER 27, 2022

Biogen alleges infringement of twenty-eight patents under the BPCIA based on Sandoz’s submission of an aBLA for PB006, a proposed biosimilar of TYSABRI (natilizumab). ” Biogen seeks a judgment that Sandoz and Polpharma have infringed or will infringe the asserted patents, and preliminary and permanent injunctive relief. .”

Marketing 52

Marketing Marketing Intellectual Property Patent 52